Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07456735
Eligibility Criteria:
Inclusion Criteria:
* Being between 18 and 65 years of age
* Having a diagnosis of myofascial pain syndrome with at least one active trigger point in the upper trapezius muscle according to the criteria of Travell and Simons
* Having signed the informed consent form regarding the study
* Having a history of muscle pain with VAS \>3 persisting for at least four weeks in the same area (upper trapezius muscle)
Exclusion Criteria:
* Having a diagnosis of cervical disc herniation, cervical radiculopathy, or myelopathy
* A history of central or peripheral nervous system disease (e.g., multiple sclerosis, stroke, peripheral neuropathy)
* Diagnosis of a major psychiatric disorder (major depression, anxiety disorder, bipolar disorder, schizophrenia) or receiving active psychiatric treatment
* Having bleeding diathesis, thrombocytopenia, or using anticoagulant/antiplatelet therapy for any reason (e.g., warfarin, clopidogrel)
* Presence of local infection at the injection site, dermatological lesions disrupting skin integrity, or signs of systemic infection
* Being pregnant or breastfeeding
* Having undergone injection, prolotherapy, or similar interventional treatment in the upper trapezius region within the last 6 months
* Having received dry needling treatment in any region previously
* A history of orthopedic or neurosurgical surgery involving the cervical spine, shoulder, or upper trapezius muscle region within the last year
* Having a diagnosis of uncontrolled diabetes mellitus or advanced-stage chronic disease (e.g., congestive heart failure, renal failure)
* Having a diagnosis of malignancy or systemic rheumatologic disease (e.g., rheumatoid arthritis, fibromyalgia syndrome, lupus)
* Having communication difficulties, cognitive impairment, or severe visual/hearing loss that could prevent participation in the study
* Having social/logistical barriers (e.g., transportation difficulties) that would prevent regular participation in the study process
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07456735
Study Brief:
Protocol Section:
NCT07456735